Repositive Overview

  • Founded
  • 2013
Founded
  • Status
  • Private
  • Employees
  • 12
Employees
  • Latest Deal Type
  • Series A
  • Latest Deal Amount
  • $2.93M
Latest Deal Amount
  • Investors
  • 21

Repositive General Information

Description

Developer of bioinformatics tools designed to solve the problems of access to human genome sequencing data. The company's tools provide data discovery of relevant genomic datasets, registration of datasets and collaboration on data projects, enabling users to secure data sharing and collaborations through a privacy-preserving platform.

Contact Information

Formerly Known As
Nucleobase
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Enterprise Systems (Healthcare)
Other Industries
Other Healthcare Technology Systems
Database Software
Primary Office
  • Betjeman House
  • 104 Hills Road
  • Cambridge CB2 1LQ
  • England, United Kingdom
+44 01223 000000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Repositive Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
13. Early Stage VC (Series A) 31-Mar-2017 $2.93M 00.000 00.00 Completed Generating Revenue
12. Accelerator/Incubator 04-May-2016 00.000 Completed Generating Revenue
11. Seed Round 02-Feb-2016 00.000 00.000 00.000 Completed Generating Revenue
10. Accelerator/Incubator 24-Jan-2016 00000 Completed Generating Revenue
9. Accelerator/Incubator 09-Oct-2015 00000 Completed Generating Revenue
8. Accelerator/Incubator 00000 00000 Completed Generating Revenue
7. Grant 30-Jul-2015 0000 00000 Completed Generating Revenue
6. Accelerator/Incubator 20-May-2015 00000 Completed Generating Revenue
5. Grant 30-Mar-2015 $150K $303K Completed Generating Revenue
4. Angel (individual) 10-Feb-2015 $303K $303K 00000 Completed Generating Revenue
To view Repositive’s complete valuation and funding history, request access »

Repositive Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 0,000 00.000000 0000.00 0000.00 00 0000.00 00.000
Ordinary 000 00.000000 0000.00 0000.00 00 0000.00 0.000
Ordinary 000 00.000000 0000.00 0000.00 00 0000.00 0.000
Ordinary 0,000 00.000000 0000.00 0000.00 00 0000.00 00.00
Ordinary 0,000 00.000000 0000.00 0000.00 00 0000.00 00.00
Ordinary 201 $1.234812 $368.6 $368.6 1x $368.6 2.29%
Ordinary 1,110 $1.234812 $222.49 $222.49 1x $222.49 12.63%
To view Repositive’s complete cap table history, request access »

Repositive Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of bioinformatics tools designed to solve the problems of access to human genome sequencing data. The company'
Enterprise Systems (Healthcare)
Cambridge, United Kingdom
12 As of 2020
00.000
0.00 0000-00-00
00000000000 00.000

0000000

Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo co
0000000000 0000000 (0000000000)
Rijswijk, Netherlands
00 As of 0000
000.00
000000&0 000.00

00 00000

lit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, qui
000000000000000000000 00000000
Zürich, Switzerland
00 As of 0000
000.00
00000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Repositive Competitors (21)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
BlueBee Formerly VC-backed Rijswijk, Netherlands 00 000.00 000000&0 000.00
00 000000000 Venture Capital-Backed Zürich, Switzerland 00 000.00 00000000000 000.00
000000 00000 Corporate Backed or Acquired Bozeman, MT 000000000 -
00000000 Venture Capital-Backed New York, NY 00 000 0000000000 000
00000000 Venture Capital-Backed Mountain View, CA 000 00000 00000000000 00000
You’re viewing 5 of 21 competitors. Get the full list »

Repositive Executive Team (11)

Name Title Board Seat Contact Info
Fiona Nielsen Co-Founder, Chief Executive Officer & Board Member
Ave Wrigley Ph.D Chief Technology Officer
Jen Nucifora Chief Product Officer
Nadia Kovalevskaya Ph.D Chief Scientific Liaison
Sheena Ohene Executive
You’re viewing 5 of 11 executive team members. Get the full list »

Repositive Board Members (6)

Name Representing Role Since
Fiona Nielsen Repositive Co-Founder, Chief Executive Officer & Board Member 000 0000
Jonathan Milner Ph.D Self Board Member 000 0000
Lennart Hergel Ananda Impact Ventures Board Member 000 0000
Michael Hedger Self Chairman 000 0000
Pierre Socha Amadeus Capital Partners Board Member 000 0000
You’re viewing 5 of 6 board members. Get the full list »

Repositive Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Repositive Investors (21)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Ananda Impact Ventures Venture Capital Minority 000 0000 000000 0
Force Over Mass Capital Venture Capital Minority 000 0000 000000 0
Kluz Ventures Venture Capital Minority 000 0000 000000 0
O2h Ventures Venture Capital Minority 000 0000 000000 0
Pinto Ventures Angel (individual) Minority 000 0000 000000 0
You’re viewing 5 of 21 investors. Get the full list »